Zhongxin Finance, May 30. The WeChat public account of "China Tongfu" issued a statement on the evening of the 29th, saying that Beijing Zhongtong Lanbo Medical Laboratory Co., Ltd., a subsidiary of China Tongfu, (hereinafter referred to as "Beijing Zhongtong Lanbo") ) is under investigation by the Beijing police regarding nucleic acid testing.
This incident has adversely affected Beijing's epidemic prevention work, and China Tongfu expresses its sincerest apology.
China Tongfu said that this incident exposed loopholes in China Tongfu's supervision and management of Beijing Zhongtong Lanbo, and it has set up a special class for the first time to fully cooperate with the work of relevant departments.
The company will deeply learn the lessons, resolutely shoulder the leadership responsibility, immediately initiate strict and quick accountability to the responsible persons of Beijing Zhongtong Lambo, and sincerely accept the accountability and handling of the responsible persons of China Tongfu from the superior organization.
Screenshot of the statement of China Tongfu Co., Ltd.
At the 349th press conference on the prevention and control of the new coronavirus pneumonia in Beijing held on May 29, the relevant departments also explained the matter. The virus nucleic acid detection operation standard, in the case of knowing that excessive mixed testing may lead to inaccurate test results, still adopts the method of multi-tube mixed testing for testing, which is suspected of obstructing the prevention and treatment of infectious diseases.
(Finish)